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Virtual models of care for people with palliative care needs living in 
their own home: a systematic meta-review and narrative synthesis 
Abstract 
Background: Access to palliative care in the community enables people to live in their 
preferred place of care, which is often home. Community palliative care services struggle to 
provide timely 24-hour services to patients and family. This has resulted in calls for 
‘accessible and flexible’ models of care that are ‘responsive’ to peoples’ changing palliative 
care needs.  Digital health technologies provide opportunities to meet these requirements 
24-hours a day. 
Aim: To identify digital health technologies that have been evaluated for supporting timely 
assessment and management of people living at home with palliative care needs and/or 
their carer(s), and the evidence-base for each. 
Design: A systematic review of systematic reviews (‘meta-review’). Systematic reviews 
evaluating evidence for virtual models of palliative or end-of-life care using one or more 
digital health technologies were included. Systematic reviews were evaluated using the Risk 
of Bias Tool for Systematic Reviews. A narrative approach was used to synthesise results. 
Data sources: Medline, Embase, Web of Science, CINAHL and Cochrane Database of 
systematic reviews were searched for English-language reviews published between 2015-
2020. 
Results: The search yielded 2,266 articles, of which 12 systematic reviews met criteria. 
Sixteen reviews were included in total, after four reviews were found via handsearching. 
Other than scheduled telehealth, video-conferencing, or after-hours telephone support, 
little evidence was found for digital health technologies used to deliver virtual models of 
palliative care. 
Conclusions: There are opportunities to test new models of virtual care, beyond telehealth 
and/or video conferencing, such as 24-hour command centres, and rapid response teams. 
Systematic Review Registration Number: Prospero CRD42020200266 
Key statements: 
What is already known about the topic? 
• Many community palliative care services struggle to provide a 24-hour service, and 
respond appropriately to the needs of patients and family in a timely way Recent 
advancements in digital health technologies provide opportunities to meet these 
requirements 24 hours a day. 
What this paper adds 
• There is limited evidence existing on the use of digital health technology, beyond 
scheduled video-conferences or telehealth to deliver integrated virtual models of 
community palliative care. 
• Further evidence is required to determine the use of digital health technology 
applications to provide a rapid virtual response, proactive care planning, or the use 
of analytics to predict deterioration in patients with palliative care needs in the 
community. 
Implications for practice, theory or policy 
• Understanding how to harness and adapt emerging digital health technologies such 
as command centres, rapid response teams and decision analytics modelling to 
improve care for terminally ill patients and their carers is critically important and 
ought to be the focus of future well-designed effectiveness trials. 
Keywords: Virtual care; palliative care, telehealth; eHealth; rapid response; remote patient 
monitoring; digital health technology; community  
Introduction 
COVID-19 has accelerated the adoption globally of various digital health technologies to 
provide care virtually. Virtual care is defined as “…any interaction between patients and/or 
members of their circle of care, occurring remotely, using any forms of communication or 
information technologies, with the aim of facilitating or maximising the quality and 
effectiveness of patient care” (p. 2).1 The integration of information and communication 
technologies and networks for the management of healthcare, (i.e. telehealth, mobile 
health (‘mHealth’), electronic health (‘eHealth’))2-4 facilitates the delivery of virtual care to 
patients and families in different locations.5 When fully optimized, digital health technology 
can facilitate the delivery of care that is continuously connected, coordinated across 
settings, delivered virtually but augmented with and integrated into existing face to face 
models of care.6 Virtual care has been demonstrated to: improve clinical outcomes in many 
specialties, enhance patient experiences, expand patient and clinician access, reallocate 
costs and improve efficiencies and enhance care coordination.6 
Timely access to optimal palliative care in the community is critical to enabling people to live 
as well as possible, optimizing time in their preferred place of care, which is most often 
home. While staying at home is desired by most, evidence suggests that home-based care 
may not perform as well as inpatient care in some domains, especially in terms of symptom 
burden.7 Inadequate symptom control and unanticipated clinical events or deterioration 
contribute to unnecessary emergency department (ED) visits for people with palliative care 
needs, especially after-hours.8, 9 Access to 24-hour professional support and advice is an 
essential element of all community palliative care services.10 These 24-hour telephone 
support services are probably the earliest form of virtual palliative care,11 and evidence 
suggests they are called upon to assess unanticipated issues that have arisen for the 
community palliative care patient, support the previously made care plans, and/or carers 
who require support  to cope with their role. Despite the importance of 24-hour access, 
many community palliative care services struggle to sustain this level of coverage.12 Calls for 
new models of palliative care to be more ‘accessible’, ‘flexible’ and ‘responsive’ to peoples’ 
changing palliative care needs and preferences have been made. However, little is known 
about how these new models of virtual palliative care ought to be configured, resourced13 
and what are the barriers and facilitators to adopting the various digital health technologies 
to deliver on this promise.13 
Aim 
To identify the digital health technologies that have been evaluated for supporting timely 
assessment and management of people living at home with palliative care needs and/or 
their carer(s), and the evidence-base for each. 
Methods 
Design 
A meta-review (a systematic review of systematic reviews) was undertaken in order to bring 
together a comprehensive summary of the evidence where there is more than one review 
on an important topic.14 Meta-reviews allow for reviews of variable quality, scope and 
strength review’s to be compared and discussed.14 The rationale for conducting a meta-
review was due to the plethora of recent systematic reviews on digital health applications in 
palliative care. While digital applications are rapidly evolving, a preliminary search of the 
literature suggested there was little evidence of initiatives beyond tele- and video-
conferencing, and remote patient monitoring. Guidance from the Joanna Briggs Institute 
informed the design, conduct and reporting of this meta-review.15 The Preferred Reporting 
Items for Systematic Reviews and Meta-analyses (PRISMA) Statement was used to guide 
reporting for this meta-review.16 
In this meta-review, systematic reviews are referred to as ‘reviews’, while studies contained 
within these ‘reviews’ are referred to as ‘studies’ (p.15).17 This meta-review sought to 
answer the following research questions: 
1) What digital health technologies have been used to provide timely and responsive 
clinical assessment and facilitate remote clinical decision making for palliative patients living 
at home who require an (unscheduled) clinical review? 
2) What was the impact of these virtual models of palliative care on clinical outcomes? 
3) What are the barriers and facilitators to delivering an integrated virtual model of 
care to people living at home with palliative care needs? 
Protocol and registration 
15The review protocol has been registered in an international prospective register of 
systematic reviews (PROSPERO CRD42020200266) (http://www.crd.york.ac.uk/prospero/). 
Eligibility criteria 
Systematic reviews (with or without meta-analysis) of original, evaluative studies, including 
quantitative, qualitative or mixed methods that adhered to the Cochrane Collaboration and 
the PRISMA statement16, 18 were eligible for inclusion if they were: published in English in a 
peer-reviewed journal; between 2015-2020; focused on digital health technology 
interventions that allowed people with advanced progressive illness living in the community, 
as defined by the Supportive and Palliative Care Indicators Tool (SPICT)19 and/or their family 
carers to receive virtual palliative care. Interventions were included if they described a 
virtual model of palliative care which utilises digital health technology to facilitate: a 
responsive assessment; decision-making; triage and/or the development of a short-term 
action or care plan, allowing for clinical information sharing and/or communication between 
clinician(s) and the person living with palliative care needs at home and/or their carer in 
response to a patient’s clinical need. 
Systematic reviews that incorporated only opinions as their primary source of evidence, 
were excluded, as were systematic reviews on virtual models of care focused on chronic 
disease self-management (i.e. education or behavioural interventions targeted at secondary 
disease management) and lifestyle modification such as ‘aging in place’ interventions, 
‘health smart homes’, assisted living technologies, home care ‘re-ablement’ interventions 
(i.e. after a stroke), or remote communication solely between clinicians without patient 
and/or carer inclusion. 
Information sources 
Databases searched included Medline, Embase, CINAHL, Web of Science and the Cochrane 
Database of systematic reviews. 
Data search 
A comprehensive search strategy was developed using Medical Subject Headings and 
keywords relating to end-of-life care, palliative care, terminal care, and hospice combined 
with terms relating to digital health technologies that supported virtual models of care 
including ‘telehealth,’ ‘video-conferencing,’ ‘telemedicine,’ ‘telecommunication,’ ‘eHealth’, 
‘mHealth,’ ‘virtual care,’ ’command centre,’ ‘concierge,’ ‘remote patient monitoring’ or 
‘RPM,’ ‘out-of-hours’ or ‘after-hours care,’ ‘unscheduled,’ ‘rapid response,’ ‘remote 
consultation,’ ‘e-triage’ and ‘information and communication technology’. The Scottish 
Intercollegiate Guidelines Network (SIGN) search filter was used to specify the search 
process with a predefined set of keywords to locate systematic reviews and meta-analyses. 
Reference lists of all included reviews and articles were also manually searched for further 
relevant systematic reviews and meta-analyses. Secondary searching of the reference lists 
of retrieved papers and of the internet via Google scholar search engine was undertaken to 
identify any additional reviews that met the inclusion criteria. 
Data inclusion/exclusion 
Study selection 
Returned articles from database searches were imported into Endnote Version 9, and 
duplicates removed automatically and double checked manually. Titles and abstracts were 
then reviewed and screened against criteria by one team member (DD), with 147 full text 
articles assessed independently by two team members (DD and JLP). Disagreements 
regarding the eligibility of studies were resolved via discussion and consensus with both 
team members, and an additional investigator, when necessary. 
Data extraction process and items 
A standardised form for extracting data and relevant information from included reviews was 
developed (DD and JLP) following Aromataris et al., guidance.15 Outcomes of interest were: 
improved clinical health outcomes for people with palliative care needs and/or their carers 
at home, such as: enhanced quality of life; a reduction in unnecessary hospitalisation or 
emergency department admissions; and lower hospitalisation costs. The feasibility and cost-
effectiveness of interventions were also of interest. Data from eligible studies were 
extracted by one reviewer (DD) and double checked (JLP). 
Risk of bias in individual studies 
Included reviews were appraised for the extent to which they had followed the 27 PRISMA 
Statement checklist.16 The JBI three phase Risk of Bias Tool for Systematic Reviews (ROBIS) 
was then applied.20 Any disagreement regarding the evaluation of studies was resolved 
through discussion and consensus involving both reviewers and a third author, when 
necessary. 
 Synthesis of results 
The initial search (up to 29 October, 2020) yielded 2,266 citations. After removal of 763 
duplicate references and screening titles and abstracts, 147 full-text reviews were retrieved 
for further assessment. After further assessment, 12 reviews were met inclusion criteria. A 
further four reviews were found via hand searching. A total of 16 reviews were included for 
synthesis (Refer Figure 1).  
A narrative approach using the UK’s Economic and Social Research Council21 methods was 
used to synthesise the systematic review results. 
(Insert Figure 1 here) 
Results 
The 16 included reviews synthesised evidence from 159 papers reporting on 150 relevant 
studies published between 1997 and 2019. Three quarters of studies (n=78, 52%) were 
reported in only one of the 16 reviews, while a very small proportion (n=4, 3%) of studies22-
25 were reported in five reviews. The reviews captured studies from a diverse range of 
countries, age groups, diseases, digital health technology and virtual care strategies, and 
outcome measures (Refer Table 1 for characteristics of included reviews). 
(Insert Table 1 here) 
Most reviewers (n=10) concluded there was insufficient evidence to support the use of 
integrating digital health technology into existing models of palliative care.26-35 The paucity 
of intervention details was highlighted as a major limitation in many reviews, making it 
difficult to determine which elements of many virtual care interventions were effective.27, 29, 
32, 34 
The overall level of evidence was low. Less than a tenth (n=11, 7%) of studies included in the 
reviews were randomised controlled trials (RCTs) (Level 1b evidence) involving: scheduled 
telephone intervention (n=5) 36-44 or scheduled video consultations (n=2),23, 45 or RPM of 
palliative care symptoms (n=2).46, 47 
The remainder of studies generated a much lower level of evidence ranging from: Level 4 
(case studies) evidence (n=42, 28%); qualitative studies (n=37, 25%) (i.e. mostly in-depth 
interviews with clinicians, patients and carers exploring user satisfaction of different virtual 
care modalities) or expert opinion (16, 11%) (Level 5 evidence) (Refer Table 2 for summary 
of included reviews). 
(Insert Table 2 here) 
Risk of bias within reviews 
The majority (n=10) of reviews had a low for risk of bias score,26, 28-30, 33, 35, 48-51 while the 
highest risk of bias was noted in a recent review.52 The risk of bias in the remaining reviews 
was unclear (n=4)31, 32, 34, 53 (Refer Table 3). The ROBIS “synthesis and findings” section 
generated the highest level of bias related to the heterogeneity in the included studies, and 
no observed meta-analyses or sensitive analyses to develop robust findings. 
(Insert Table 3 here) 
Synthesis of results 
Video consultations 
The overall consensus in the reviews was that scheduled video consultations are an 
effective, accessible and a cost-effective way to deliver healthcare remotely but are not 
better than face-to-face consultations. However, it was noted that if scheduled video-
conferencing is to be augmented with usual palliative care, then services needed to ensure 
that the software is simple, effective, reliable and safe, with the highest level of security for 
confidentiality.52 
Video consultations, using a variety of applications were predominately adopted by high-
income country specialist palliative care services and provided to cancer patients.30, 31, 33-35, 
48-53 Scheduled follow-up video consultations, involving the patient, family and/or other 
clinicians were often employed after the initial face-to-face specialist palliative care 
consultation49, 52 and focused on providing ongoing clinical support or symptom 
management and/or psychotherapy.35, 48 
Six reviews that included two Phase III RCTs23, 45 (Level 1b evidence) found scheduled video 
consultations to be as effective as conventional face to face palliative care consultations.33-
35, 49, 51, 52 While the Hebert et al.23 RCT found no additional improvements with the use of 
video capabilities, the Demiris et al.45 RCT showed a significant improvement in carers’ 
quality of life and reduction in their anxiety for those using scheduled video consultations. 
Telephone consultations 
Mixed evidence emerged from the 9 reviews reporting on the effectiveness of scheduled 
telephone consultations.26, 31, 33-35, 48, 51, 53 Telephone consultations were used for 
counselling,34, 51 delivery of nursing support,31, 34, 50 education,50 and multidisciplinary team 
communication.50 
Seven Phase III RCTs (Level 1b evidence)36-42, 44, 54, 55 tested scheduled telephone 
consultations and generated mixed results. All of these interventions augmented scheduled 
telephone support with either: psycho-educational support,36-39 automated symptom 
monitoring;54 or nursing support.42, 44 The INCPAD (Indiana Cancer Pain and Depression) 
trial43, 54, 56 reported in Allsop et al.29 review, augmented scheduled telephone support with 
automated symptom management to significantly improve advanced cancer pain (P<.001) 
and depression outcomes (P<.001). The ENABLE trial, reported in Pinto et al. review53 
similarly improved quality of life (P=.02) and depression (P=.02).36 Two end-stage renal 
failure Phase III RCTs found that a nurse-led scheduled telephone follow-up post-discharge: 
1) improved peritoneal dialysis patients well-being, pain and fatigue44 (both reported in the 
Lunney et al.31 review); and 2) significantly improved depression (P=.05), anxiety (P=.01) and 
stress scores (P=.001) in community haemodialysis patients.41 In the Phase III RCT42 (Level 
1b evidence) telephone monitoring reduced patients anxiety (P<.0001), depression 
(P<.0004), and overall distress (P<.0001) and a similar trial reported significantly fewer 
outpatient clinic visits at 12 weeks.44 
However, a Phase III RCT (Level 1b evidence)55 included in the Ostherr et al.50 review found 
no difference in the care outcomes of community palliative care patients who received 
scheduled telephone access to multidisciplinary specialist palliative care team advice and 
support compared with limited telephone advice, with both groups reporting significant 
improvements in: symptoms (P<.001 vs. <.001), health-related quality of life (P<.001 vs. 
0.044), mood (P<.001 vs. 0.13) and emotional problems (P<.001 vs. 0.008), suggesting either 
models of telephone support can result in improvements in health-related outcomes.55 
Conversely, Phase III ImPaCT RCT found that weekly palliative care telephone consultations 
(N=74) led to worse anxiety scores (P=.04) and no difference in depression scores (P=.73) 
compared to usual care among ‘home-dwelling’ patients with advanced cancer (Level 1b 
evidence).40 Excess attention on symptoms and (potential) suffering, the supply-driven care 
model for telephone consultations in the trial, and the already high level of specialist 
palliative care provided to the control group in the study may have contributed to these 
results.40 
Remote patient monitoring (RPM) 
Eight reviews reported on RPM as part of a virtual model of palliative care.26, 29-31, 33, 35, 50, 53 
These RPM interventions included the monitoring of biometric data (i.e. heart rate, blood 
pressure, respiration rate) or symptoms such as pain, either actively by nurses or through 
generated alerts to clinicians when patient scores reported outside of a predetermined 
acceptable threshold,35, 50 both within hours and after-hours. Patients manually inputted 
data on symptoms specific to their illness using their telephone landline, television or 
computer hardware and software. Alerts triggered clinicians remotely to contact the patient 
or to visit them at home.  
Two phase III, RCTs testing the effectiveness of RPM (Level 1b evidence)46, 47 reported no 
difference in outcomes. The TeleCRAFT trial involving patients with chronic obstructive 
pulmonary disease found no difference in median number of days spent at home (P=.189) 
or quality of life (P=.270).46 This RPM intervention actually increased hospital admissions 
(P=.026) and home visits overall,46 reflecting the need for a clinical review based on 
abnormal parameters and potentially an inability to review the patient virtually. Conversely, 
the other RPM RCT which sent alerts directly to the patient’s surgeon reduced postoperative 
symptoms in patients with advanced lung cancer or lung metastases (75% Stages III and IV 
lung cancer) (P=.02).47 
Mobile applications 
Eight reviews described the use of smartphone and mobile applications (‘apps’) to allow for 
communication and information sharing between patients and/or carers and clinicians.28, 32-
35, 48, 50, 53 Two systematic reviews28, 53 provided comprehensive lists of available apps 
relevant to palliative populations which: provide information on palliative care medication; 
enhancing communication; provide systems to monitor and assess symptoms; and 
synthesise patient information and end-of-life care wishes. Limited information was 
provided as to whether these mobile applications allowed for after-hours contact with 
clinicians. However, no well-designed studies have tested the effectiveness of these apps or 
their impact on delivering virtual models of care. 
Telephone advice and support lines 
Five reviews reported on dedicated after-hours telephone support and advice lines,27, 30, 32, 
33, 50 and has been reported as the most common type of digital health technology used to 
provide a virtual palliative care model.57 However, none of the studies reported in included 
reviews generated robust (level 1b) evidence. Telephone advice and support lines required 
adequate staffing and infrastructure support in order to be sustained.57 Despite palliative 
care telephone advice lines being widely adopted, a recent review27 was unable to 
determine the effectiveness and cost-effectiveness of after-hours palliative care telephone 
support and advice lines, due to a paucity of suitably designed studies.27 
Barriers and facilitators to delivering a virtual model of community palliative care 
Five reviews described a range of barriers and facilitators that impact on the delivery of 
virtual models of community palliative care34, 35, 48, 49, 52, 53 (Refer Table 4). 
Barriers: Four reviews reported clinicians concerns that video consultations and RPM 
devices are inappropriate for this population due to illness burden and potential for rapid 
deterioration.30, 34, 35, 52 Several reviews highlighted clinician preference for face-to-face 
interactions over virtual encounters48, 49 because it allows for better engagement, 
observation and examination of the patients,53 and an opportunity to discuss sensitive 
topics and to comfort distressed patients.48, 52 Technical issues were considered major 
barriers to providing virtual care, especially limited broadband or internet access30, 53 and 
slow internet speed affecting the quality of the video and audio resolution.48, 49, 52 
Facilitators: Four reviews also highlighted clinicians positive perceptions of video enabled 
consultations due its ability to enable digital connectedness,35, 48, 49, 52 and a way to observe 
body language and nonverbal cues, and to understand the patient’s health status and make 
appropriate changes to their management plan. Building patients and families digital health 
capabilities was considered a key facilitator to the success and viability of virtual models of 
care, especially for older people and those less familiar with technology.48, 49, 52, 53 Tailoring 
the use of technology to patients and carer preferences and capabilities was also noted as 
being important.48, 49, 51 Building clinicians’ video consultation capabilities is also critical to 
improving the quality of virtual palliative care service delivery.49, 52 Several reviews 
highlighted the need for improved infrastructure and access to external supports to 
optimise the integration of available digital health teachnology into existing models of 
care.30, 48, 49, 52 
 (Insert Table 4 here) 
Impact on health service utilisation 
There was mixed evidence of the impact of virtual palliative care on health service 
utilisation. Three reviews reported on hospital and emergency department visits,30, 31, 34 and 
four reviews reported on cost-effectiveness.27, 33, 34, 52 As most of this data was generated 
from Phase II studies, it is difficult to draw any firm conclusions. 
Five studies in the Lunney et al.31 reported on the impact of virtual care strategies as an 
adjunct to usual palliative care on health services utilization for patients with ESRD, with 
four studies finding positive results,44, 58-60 with only one a Phase III trial design.44 Li et al.44 
reported significantly fewer clinic visits with telehealth at 12 weeks following 
implementation. Two Phase II trials reported encouraging findings which could not be 
confirmed, while the other detected no difference.58, 60, 61 A third review30 which included a 
very different group of studies, reported insufficient evidence to appreciate any benefit of 
telehealth on emergency department visits. 
Three reviews reported on cost-effectiveness of virtual care strategies for palliative care,27, 
34, 52 with two reporting positive outcomes.34, 52 Sutherland et al. review52 included two 
Phase III trials showing a cost reduction by providing patients with technology to access 
video consultations compared with outpatient appointments or inpatient admission.23, 45 
Head et al. review 34 included two studies which showed virtual care can significantly drop 
hospital care costs,62, 63 however these were from Phase II trial results. 
Discussion 
Overall, there is insufficient evidence describing the impact of integrating virtual care 
strategies into existing community palliative care models. Due to the low quality of 
evidence, it was difficult to evaluate the individual effectiveness of the four main digital 
health technology strategies (i.e. information and communication technology, telehealth, 
mHealth, and eHealth) employed to deliver a virtual model of care to community palliative 
care patients. 
Despite the proliferation of reviews, there is insufficient evidence available to identify the 
key elements of an optimal integrated virtual community palliative care model. Few of the 
reviews detailed virtual care intervention that provided responsive clinical assessment or 
facilitated remote care to this population, including an unscheduled and rapid clinical 
review. Compounding this problem, is the lack of population level prevalence data to guide 
planners as to the actual need for unscheduled reviews and the triggers and timing of this 
need in the context of people with palliative care needs living at home. 
After-hours, unscheduled, e-triage or rapid response elements were minimally if at all 
described in any of the virtual care interventions reported on in this meta-review. While 24-
hour telephone support lines are the oldest and most widely adopted virtual model of 
palliative care, there is little evidence demonstrating their effectiveness.27 Scheduled video 
or telephone consultations were the most commonly used digital health technology to 
provide virtual care, which are neither new nor novel. Of note, none of the reviews reported 
on or mentioned the need to develop and test more integrated virtual models of community 
palliative care or the potential role of providing: real-time assessment, triage and/or review 
via 24-hour command centres; or concierge services to assist palliative care patients and 
their carers navigate their care needs in a timely manner.  
The COVID-19 pandemic has accelerated the global uptake of digital health with healthcare 
organisations rapidly adopting virtual care solutions. A recent systematic review looking at 
the uptake of digital health solutions to mitigate the impact of COVID-19 on people in health 
systems identified numerous suggestions on the use of artificial intelligence powered tools 
for diagnosis and screening for the virus.64 Similar to this meta-reviews’ findings, the use of 
telehealth tools like video-conferencing and apps were proposed. Th historical moment 
associated with this pandemic may encourage decisive large-scale adoption in the 
healthcare system, which have been particularly resistant in the past, and hopefully a 
greater integration into homebased palliative care programs. 
Future integrated models of virtual palliative care need to apply the lessons learned through 
the pandemic as well as from previous after-hours initiatives.65, 66 It will be critical to ensure 
that that communication between community patients and members of their healthcare 
team is: flexible, responsive and tailored to regional circumstance; makes efficient and 
effective use of the broader health workforce; and uses data to drive improvements and 
inform policy.66 
There was also no consideration or explanation in any of the included reviews of the 
importance of providing integrated virtual palliative care across diverse: services (i.e. public 
and private); settings (i.e. primary, acute or aged care); and/or team members (i.e. general 
practitioner, community nurses, specialist providers). There is a need for virtual palliative 
care to move towards integration of scheduled and after-hours telehealth services in order 
to provide timely and responsive care across a large region, with quality care provided 
within hours and after-hours guided principally on patient need. Healthcare organisations 
adopting an enterprise approach that maximises resources, creates more efficient 
operations, consolidates the limited workforce, delivering care to scale and breaking down 
silos of care.67 
Moving to an integrated virtual palliative care model also requires consideration of a 
number of factors.  Establishing a virtual model of palliative care is in essence not just the 
introduction of new technology, but rather the creation of a new service.68 Drawing on their 
digital health technology and palliative care expertise, Calton et al. 69 highlighted that the 
most successful virtual palliative care models are those that: 1) complete a service needs 
assessment; 2) have a billing model; and 3) build clinician’s capabilities to optimise the 
provision of virtual care and to recognise when in-person care is required.69 Applying the 
simple heuristic ‘Tool, Team and Routine’ framework will help palliative care services to 
identify the key questions, stakeholders and issues requiring attention to enable an effective 
virtual model of care to be effectively established.68 The type of issues that will need to be 
considered in order to operationalize a virtual model of palliative care ,include: the 
development of standardised agreed comprehensive assessments, proactive care planning 
by day-time team and standardised interdisciplinary team handover and communication 
processes. Further development of the virtual palliative care evidence-base is required to 
understand its impact on patient and clinician experiences, patient outcomes such as 
symptom management and well-being, health service utilisation, and costs; and quality and 
safely.69 
A Phase II prospective cohort study has demonstrated the feasibility and acceptability of an 
integrated multicomponent digital health intervention for community-based patients (n=43) 
seen by a specialist palliative care service.70 Integration of video and self-reported outcome 
measures fed back to specialists helped to identify patients in need of a timely review of 
care,70 with clinicians reporting video consultations as similar or better/much better than 
phone calls or face-to-face visits.70 However, delivering this model of virtual care required 
timely technical support, increase in service staff to manage the volume of alerts generated 
and address the impacts of these service changes on team functioning. 
There is conflicting evidence on the effects of virtual models of palliative care on the use of 
hospital department and emergency department visits.30, 31, 34 While all of the Phase III 
virtual care trials demonstrated reduced health service utilization,23, 44, 45 none considered 
the impact on safety and quality of the care provided. Determining what can be realistically 
managed virtually and which clinical situations demand a face-to-face review is an 
important next step. While any virtual intervention that enables community palliative 
patients to spend even another day ‘safely’ at home is likely to reduce healthcare costs, 
there is a need to ensure that it doesn’t increase carer distress, burden or impact adversely 
on household finances. Future research needs to evaluate the impact of new models of 
virtual care in healthcare service utilisation and costs. 
Numerous barriers and facilitators at the system, health provider and patient level have 
been identified in this meta-review, as summarised below. 
Systems level: Limited broadband or internet access, and slow internet speed are major 
barriers to providing virtual care. The 2018 cross sectional American Survey,71 found that 
26.3% of Medicare beneficiaries, mainly older people, those with low socio-economic status 
and those from minority ethnic communities, lacked digital access at home, which limited 
their opportunity to receive virtual healthcare (i.e. video consultations with clinicians).71 
Similarly, it is estimated that 2.5 million Australians are not online which impacts on their 
ability to benefit from innovative models of virtual care.72 A lack of digital inclusion has the 
potential of widening disparities in care and will adversely impact the delivery of new 
accessible and affordable virtual models of palliative care that are available to all. 
Clinicians: Several reviews reported clinicians concerns that virtual care is not always 
appropriate for palliative populations due to their age, symptom burden and potential for 
rapid deterioration.30, 34, 35, 52 While several reviews documented health professional 
preference for face-to-face consultations with patients, the global COVID-19 pandemic has 
triggered the expansion of digital health technology to provide virtual care, and a shift in 
health professional’s attitude and overall uptake.64 Determining what palliative care needs 
can be managed virtually and what needs require in-person assessment, at home or in 
hospital is essential to developing a sustainable, safe, high quality virtual model of palliative 
care. 
Patients and carers: Palliative care patients in the community require close follow-up in 
order to identify changing palliative care needs.73 A virtual model of palliative care 
addresses these needs by optimising existing digital health technology to respond rapidly to 
the alerts triggered by RPM, via a bi-directional remote communication system that allows 
for assessment, planning and triage at any time of the day or night. Considering how to 
support older and digitally inexperienced patients to build their level of digital health 
technology confidence and preparedness to engage with virtual care is an important 
consideration of any future models of virtual palliative care. This is especially important with 
72% of adult Americans aged over 85 years living at home identified as unprepared to 
participate in video and telephone consultations,74 due to inexperience with technology, 
lack of social support to instruct them on using this technology, and lack of confidence 
about interacting virtually. Hearing, communication difficulties or dementia limited a fifth 
(20%) of these older adults from participating in scheduled telephone consultations.74 
Addressing these barriers along with building patients and families’ digital health capabilities 
is a key facilitator to enabling the delivery of any virtual model of care. 
Limitations and strengths 
This meta-review has a number of limitations and strengths. Most included reviews defined 
‘virtual care’ very broadly and did not attempt to delineate the effectiveness of the various 
digital health technologyused to provide timely care to people with palliative care needs 
living at home. The inconsistency and heterogeneity in the definition and terminology of 
telehealth in the literature has been long noted as a major challenge,75 and may have led to 
relevant reviews being excluded. The studies included in the various reviews were 
heterogeneous in terms of the digital health technology used to provide virtual care, 
intervention duration, populations studied and outcomes assessed. This heterogeneity 
limited the ability of any of the reviews to undertake a meta-analysis. While publication bias 
is a risk because the search did not extend to the grey literature, this is balanced by the 
group consensus methods which have mitigated against this risk. Conducting a meta-review 
may have precluded more recent  virtual care interventions (i.e. 24-hour concierge and tele-
porting) from being captured. However, this limitation is off-set by this being the first meta-
review of its kind focusing on understanding the use of digital health technology to support 
the delivery of an integrated model of virtual community palliative care. The limited overlap 
of original studies between included reviews supports the rationale for adopting the meta-
review design. While adherence with the internationally recognised protocol for the 
conduct and reporting of systematic reviews, the PRISMA Statement 16 strengthens the 
validity of the results. 
Conclusions 
There is limited evidence that existing digital health technology, beyond scheduled video-
conferences or telehealth are being fully optimised to deliver integrated virtual models of 
community palliative care. To date, there has been little focus on using digital health 
technology applications to provide a rapid virtual response or to provide new services. 
There is also little evidence of proactive care planning, or the use of analytics to predict 
deterioration in patients. Despite these gaps, there is great potential to develop and test 
integrated virtual care interventions that will help to revolutionise the delivery and 
organisation of healthcare for people with palliative care needs who wish to spend as many 
days as possible at home. Understanding how to harness and adapt new and emerging 
digital health technology to improve care for terminally ill patients and their carers is 
critically important and ought to be the focus of future well-designed effectiveness trials 
and decision analytic modelling. 
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Table 1. Characteristics of reviews (N=16) 
Characteristics  Number of studies (%) Citations 
Countries/regionsα 
  
United Kingdom 10 (63) 29-31, 34, 35, 48-50, 52, 53 
USA 10 (63) 26, 29, 31, 34, 35, 49-53 
Australia  8 (50) 26, 35, 48-53 
Canada 8 (50) 26, 31, 34, 35, 49-52 
Japan 7 (44) 29, 31, 35, 49, 50, 52, 53 
The Netherlands 5 (31) 26, 35, 49, 50, 52 
Brazil 4 (25) 35, 49, 52, 53 
Sweden 3 (19) 29, 34, 35 
India 2 (13) 34, 50 
Norway 2 (13) 29, 53 
Spain 2 (13) 31, 50 
Portugal 2 (13) 26, 35 
Switzerland 1 (6) 26 
Germany 1 (6) 26 
Iran 1 (6) 31 
China 1 (6) 31 
Korea 1 (6) 50 
Austria 1 (6) 29 
Hong Kong 1 (6) 31 
Germany 1 (6) 29 
Taiwan 1 (6) 51 
Sub-Saharan Africa 1 (6) 32 
New Zealand 1 (6) 26 
   
Age groups   
All ages/ no restrictions on age 11 (69) 29-34, 49-53 
Adults (18+) 5 (31) 26-28, 35, 51 
Paediatrics 1 (6) 48* 
   
Primary Diagnosisβ   
Cancer 10 (63) 26, 28-30, 32, 34, 35, 49-51 
COPD 5 (31) 26, 28, 30, 35, 49 
Heart failure 4 (25) 28, 30, 34, 51 
Chronic kidney disease/ end-stage 
renal disease 
3 (19) 30, 31, 34 
Life-limiting condition (broad) 2 (13) 48, 49 
Cystic fibrosis 2 (13) 30, 35 
Multiple sclerosis 2 (13) 26, 35 
Amyotrophic lateral sclerosis 2 (13) 26, 35 
Respiratory failure (non-COPD) 1 (6) 30 
HIV/AIDS 1 (6) 32 
Advanced dementia 1 (6) 30 
Motor neurone disease 1 (6) 30 
   
Virtual care strategy (DHT use)    
Scheduled review (video consultation) 
 
12 (75) 26, 30, 31, 33-35, 48-53 
Scheduled review (telephone 
consultation) 
 
9 (56) 26, 31, 33-35, 48, 50, 51, 53 
Self-management (mobile applications) 
 
8 (50) 28, 32-35, 48, 50, 53 
Symptom management (RPM) 8 (50) 26, 29-31, 33, 35, 50, 53 
24 hour support (telephone advice 
lines) 
5 (31) 27, 30, 32, 33, 50 
Patient/carer information 
(websites/internet) 
3 (19) 33, 34, 50 
Symptom management, psychosocial 
support (SMS text messaging) 
2 (13) 32, 50 
Communication with patients/ health 
professionals (Email and/or Faxing) 
2 (13) 50, 53 
Symptom management (PalmPilot / 
pen tablets) 
2 (13) 33, 50  
   
Outcomes measured   
Health-related outcomes   
Patient-physician communication/ 
relationship 
4 (25) 26, 33, 50, 53 
Clinical health-related outcomes 
(broad)  
3 (19) 33, 35, 48 
Symptom management/ reduction 3 (19) 26, 33, 34 
Self-reported health outcomes (broad) 2 (13) 35, 48 
Quality of life 2 (13) 33, 34 
Patient anxiety/depression/ 
psychological wellbeing 
2 (13) 31, 34 
Pain assessment / management 2 (13) 29, 33 
Caregiver quality of life 1 (6) 51 
Caregiver mood/anxiety 1 (6) 51 
Caregiver perception of pain 
management 
1 (6) 33 
Physical function 1 (6) 31 
Caregiver burden 1 (6) 51 
Family functioning 1 (6) 51 
Social support 1 (6) 51 
Surrogate measures e.g. blood 
pressure, disease-related process 
measures 
1 (6) 31 
 
   
Health service utilisation   
Hospital/ED admissions and/or 
readmissions 
3 (19) 30, 31, 34 
   
Intervention related outcomes   
Patient and/or carer perceptions / user 
satisfaction/ satisfaction with care / 
experience measures 
6 (38) 26, 27, 30, 31, 34, 35 
General usage/usability 5 (31) 26, 30, 32, 52, 53 
Cost / Cost-effectiveness 5 (31) 27, 30, 33, 34, 53 
Efficacy/effectiveness 4 (25) 27, 31, 33, 50 
Advantages/disadvantages of 
intervention 
3 (19) 33, 49, 53 
Feasibility of intervention 2 (13) 26, 33 
Barriers/facilitators of intervention 2 (13) 49, 53 
Features for family support and 
caregiving functionality 
1 (6) 28 
Compatibility 1 (6) 53 
Patient acceptance/compliance of 
intervention 
1 (6) 33 
Sense of safety and patient security 1 (6) 26 
Level of Digital Service Standard 
compliance 
1 (6) 30 
Intended location of use 1 (6) 32 
Stage of development 1 (6) 32 
COPD, chronic obstructive pulmonary disease; DHT, digital health technology; ED, emergency department; 
HIV/AIDS, Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome RPM, remote patient 
monitoring; SMS, short message service; USA, United Stated of America 
α Rogante et al.33 and Portz et al.28 did not report on the country of origin of their included studies. Johnston et 
al. included no studies. 
β Sutherland et al.52 did not provide information on the primary diagnoses of patients in included studies. 
*Holmen et al. 48 also included studies with adult populations 
Table 2. Summary table of included reviews 
Source (Years 
covered by review) 




Countries /  
Regions 
Included studies (N) 
 
Type/level of evidence 
Participants  
(N)/ condition  
Intervention Outcomes Conclusions 
Widberg et al. 
202026 
(2014-2019) 










YES – PRISMA 16 
 
YES - Quality appraisal: 







N = 12 
 
• RCT (n=1) 
• Prospective, uncontrolled, multi-
centered (n=1) 
• Prospective cohort study (n=1) 
• Cross-sectional study (n=1) 
• Feasibility / acceptability pilot 
study (n=3) 
• Interview and/or focus groups 
(n=3) 
• Prospective, longitudinal, 
qualitative, descriptive design 
with case studies (n=1) 
• Mixed methods (n=2) 
 




• Amyotrophic lateral 
sclerosis (ALS) 






• Video consultation 
• RPM 
• Patient experience 
• Usability/feasibility of 
eHealth applications 
• Symptom control and 
individualized care through 
eHealth applications 
• Sense of security and patient 
safety 
• Patients’ experiences were that 
eHealth promoted individualized care, 
sense of security, better symptom 
management and participation in care. 
• Communication was facilitated by the 
inherent flexibility provided by 
technology. 
Portz et al. 2020 28 
(2010-2019) 













YES –PRISMA: uses 
extension for Scoping 
Reviews 76 
 
NO - Quality appraisal  
Not reported N = 10 
 
• Protocol (n=4) 
• Pilot (n=4) 
• Descriptive survey (n=1) 
• Mixed methods (n=1) 
 






• Mobile apps 
 
• Palliative care element 
• Target user 
• Features for family support 
and caregiving functionality 
• There is an emerging presence of apps 
for patients and social convoys 
receiving palliative care. 
• Additional research is needed for apps 
that embrace a team approach to 
information sharing, target family- and 
caregiver-specific issues, promote 
access to palliative care, and are 
comprehensive of palliative needs. 
Johnston et al. 2020 
27 
(1998-2018) 
To determine the 
effect of out-of-
hours specialist and 
generalist palliative 
care services on 
patient and family/ 
caregiver outcomes, 






YES – PRISMA 16 
 
YES - Quality appraisal: 
CASP Tools 75 
NA N = 0  
 
• RCTs 
• Prospective/ retrospective 
cohort studies 
• Before-and-after studies 
• Economic evaluations 
• Qualitative/descriptive studies 
• Pilot studies 
 
NA NA • Patient and family/caregiver 
outcomes 
• Costs and cost-effectiveness 
• One study was identified in the peer-
reviewed literature, but was deemed 
of insufficient quality. 
• The importance of integrated, 24-hour 
care for people in line with a palliative 
care approach is not reflected in the 
literature, which lacks evidence on the 
effects of interventions provided 
outside typical working hours. 









in palliative care. 
Rapid review of 
systematic reviews  
 
Narrative synthesis  
 
NO – PRISMA (not 
explicit) 
 





N = 34 
 
Level 1a Systematic Reviews, 
including:  
 
• Quantitative (n=10), including 
one RCT (n=1) and case studies 
(n=5) 
• Mixed methods (n=14)  
• Qualitative (n=10) 
N = 2345 patients with 
palliative care needs  
 
N = 549 carers /NOK 
 
N = 252 HPs 
• Video consultation 
 
Did not stipulate primary and 
secondary outcomes 
- Included studies focused on any 
outcome and general usage 
• Video consultations are an effective, 
accessible, acceptable and cost- 
effective method of service delivery. 
• Organisations must ensure software is 
simple, effective, reliable and safe, 
with the highest level of security for 
confidentiality. 
Steindal et al. 2020 
35 
(2000 – 2018) 
To map and assess 
the use of telehealth 









YES – PRSIMA: uses 
extension for Scoping 
Reviews 76 
 






N = 22 
 
• RCTs (n=3) 
• Quantitative (n=7) 
• Case studies (n=3) 
• Mixed/multi-methods (n=9) 
• Qualitative (n=2) 
 
 
N = 644 patients with 
palliative care needs as 
a result of: 
• COPD 
• Cystic fibrosis 
• Cancer 
• Multiple sclerosis 
• Amyotrophic lateral 
sclerosis 
 




• Webinar technology 
• Mobile phones 
• PDAs 





• Patient reported subjective 
and objective outcomes 
• Patient experience 
 
• Telehealth in palliative home care 
seems to be feasible, improving access 
to health care professionals at home 
and enhancing feelings of security and 
safety. 
• The visual features of telehealth seem 
to allow a genuine relationship with 
health professionals. However, there 
are contradicting results on whether 
the use of telehealth improves 
burdensome symptoms and QOL. 
Holmen et al. 2020 
48 
(2012-2016) 
Identify and review 













by-line coding) and 
convergent synthesis 
 
YES – PRISMA 16 
 
YES – Quality appraisal: 
Joanna Briggs Institute 
using Standardised 
checklists for primary 
studies 77 
Australia, UK N = 7 
 
All studies evaluated an 
intervention. One study aimed for a 
controlled design but ended 
recruitment prematurely because of 










• Video conference 
• Telephone 
• Web-based tool 
• Health-related outcomes 
(self-reported and objective 
measures 
• Regardless of technology, children 
need an individual approach.  
• Child and family preferences as well as 
the former’s care needs can guide the 
tailoring of eHealth technology. 
• Some HPs preferred videoconferences 
to telephone calls. 
• HPs perceived using devices in addition 
to the burden of having a child with 
palliative care needs seemed 
demanding of the parents. 
Jess et al. 2019 49 
(2005-2018) 
To analyse the 
barriers and 










YES – PRISMA 16 
 
YES – Quality Appraisal: 






N = 39 
 
• Quantitative (n=10) 
• Case studies (n=5) 
• Mixed methods (n=14) 
• Qualitative (n=10) 
n = 2345 patients 
 
n = 549 relatives 
 
n = 252 HPs 
 





• Video consultation • Advantages/ disadvantages 
• Barriers/ facilitators 
• Video consultations in palliative care 
mainly focused on specialised palliative 
care settings in high-income countries 
and patients with a cancer diagnosis.  
• It is important to include the 
perspective of patients and relatives as 
well as HPs when evaluating the use of 
video consultations in palliative care. 
Hancock et al. 2019 
30 
(2010-2018) 
To describe the 
current use of 
telehealth in 
palliative care in the 
UK and evaluate 
telehealth initiatives 






YES – PRISMA 16 
 
YES – Quality Appraisal 
according to Wallace. 
et al 79 
UK specific N = 30 
 
• RCTs (n=3) 
• Randomised crossover trial (n=1) 
• Realist evaluation (n=1) 
• Prospective interventional (n=1) 
• Prospective longitudinal cohort 
(n=1) 
• Prospective observational (n=2) 
• Retrospective observational 
(n=2) 
• Service evaluations (n=4) 
• Description of intervention 
without an identifiable design 
(n=3) 
• Mixed methods (n=1) 
• Protocols (n=3) 
• Qualitative (n=7) 
n= 6617 patients/ 
caregivers 
 
n= 298 HPs 
 
Sample range: 3 – 3594 
 
Patients with palliative 
care needs: 
• COPD 
• Respiratory failure 
• Renal failure 




• Metastatic breast 
cancer 
• Motor neurone 
disease 
• Cystic fibrosis 
• Advanced dementia 
Telehealth: 
• RPM 
• Digital support via 
telephone or video 
• General usage in palliative 
care 
• Level of Digital Service 
Standard compliance 
• Acute or emergency services 
use 
• Cost-effectiveness 
• User perception 
• Although there is growth of telehealth 
services, there remains a lack of 
evaluation and robust study design 
limiting conclusions regarding the 
clinical application of telehealth in 
palliative care. 
• There is insufficient evidence to 
appreciate benefit of telehealth on 
access to emergency care. 
• Future work is needed to evaluate the 
use of telehealth in palliative care and 
improve telehealth design in line with 
digital service standards. 
Allsop et al. 2018 32 
(1990-2015) 
To identify the 
development and 








YES – PRISMA 16 
 
NO – Quality appraisal  
Sub-Saharan Africa: 
Kenya, Malawi, 
Uganda, Nigeria,  
N = 5 
 
• Pre-test and post-test 
questionnaires to evaluate an 
education intervention for HPs 
(n=1) 
• Descriptive analysis of data 
captured from patient contact 
with HPs using a mobile phone 
alongside findings from 
interviews with patients about 
experience using mobile phones 
as part of their care (n=1)  
• Rapid evaluation (n=1) 
• Questionnaire (n=1) 









Patients with palliative 
care needs and their 
carers/families: 
• Cancer 
• HIV / AIDS 
mHealth: 
• Mobile phones 
• RPM device 
• Personal digital 
assistants 
• Wireless devices 
• Telephone 
• SMS text messaging 
• Regions and use of mHealth 
• Intended location of use 
• Stage of development 
• Existing mHealth interventions for 
palliative care in sub-Saharan Africa 
are limited in number, and are 
developed for use at the palliative 
treatment, guidance and coordination 
stage of care provision. 
• Levels of detail about development 
and structure of interventions are low. 






quality of care for 





NO – PRISMA (although 
provides a PRISMA 
flowchart) 
 
NO - Quality appraisal 
(used the TIDieR 
checklist 80 for 
reporting) 
US, Hong Kong, UK, 
Spain, Japan, Iran, 
China, Canada 
N = 11 
 
• Randomised trials (n=7) 
• Cohort studies (n=3) 
N = 2611 
 






• Video conference 
• Effectiveness 
• Hospitalisation; patient-
reported outcomes: (physical 
and mental status) 
• Experience measures 
• Surrogate measures e.g. BP; 
ESRD process measures 
• Study populations, modes of telehealth 
delivery and outcomes evaluated 
varied substantially between studies. 
• Two studies examined telehealth 
interventions versus standard ESRD 
care, demonstrating mixed results on 
processes of care, no differences in 
laboratory surrogate markers of ESRD 
care, and reduced or similar rates of 
hospitalisation.  
• Eight studies evaluated the addition of 
telehealth to usual care and 
demonstrated no significant 
improvements in processes of care or 
surrogate laboratory measures, 
variable impacts on hospitalisation 
rates, and mixed impacts on some 
domains of QOL, including 
improvement in mental health. 













YES – PRISMA 16 
 
YES -  Quality appraisal: 
Quantitative -Cochrane 
Collaboration tool 81 
Qualitative - a checklist 
was used to evaluate 
trustworthiness of the 
methodology82, 83 
India, Canada, UK, 
Sweden, US 
N = 11 
 
• Quantitative (n=6) 
• 2-group randomized controlled 
trial pre-test/ post-test design 
(n=1) 
• 2-group comparison design (n=2) 
• Single-group pre-test/ post-test 
(n=1) 
• Single-group non-experimental 
survey design (n=1) 
• Quantitative mixed methods 
(n=1) 
• single-group design (n=1) 
• case studies (n=3) 
• qualitative (n=15) 
• qualitative mixed-methods (n=3) 
n = 1741 patients 
 
n = 9 HPs 
 
Sample range: 1-1352 
 
Patients receiving 
palliative or EOL care 









• Computer programs 
with internet access 
• Smart phone 
applications 
• QOL 
• Symptom management 
• Patient satisfaction 
• Depression/anxiety 
• Hospital visits 
• Cost 
• Support for positive patient outcomes 
in palliative telehealth interventions 
was weak.  
• However, all studies but one found 
positive results to support the 
intervention. Results across studies 
were also variable. 
Pinto et al. 2017 53 
(up until 2016) 
To analyse the use 
of e-Health 
technologies and 






NO – PRISMA (not 
explicit) 
 
NO– Quality appraisal  
US, Australia, UK, 
Norway, Japan, 
Brazil 
N = 25 (studies) 
 
• RCT (n=4) 
• Cost minimization analysis (n=1) 
• Evaluation study (n=1) 
• Feasibility study (n=3) 
• Pilot study (n=6) 
• Case series (n=3) 
• Case study (n=3) 
• Mixed methods (n=3) 
• Interviews (n=1) 
 
n = 40 (Apps) 
Not reported 
 
• Palliative care 
eHealth technologies: 
• Video conferencing 
• Telephone 
• RPM 
• Mobile apps 
• E-mail 
• Use 
• Availability of mobile apps 
• Strengths, weaknesses, 
opportunities and threats of 
these technologies 
• Compatibility and charges for 
the app 
• Main objective of the app 
• Level of communication 
• Teleconsultation is the principal e-
Health technology. 
• Mobile applications focused on 
communication, drugs, tools/clinical 
guidelines, hospice, symptom 
management and palliative care 
information. 
Ostherr et al. 2016 
50 
(1997-2013) 
To identify the ICTs 
being used in EOL 
communication. The 
secondary objective 
was to compare the 
effectiveness of 






YES – PRISMA 16  
 
YES - Quality Appraisal: 
Cochrane 
Collaboration’s Tool 81 




N = 38 
 
• RCTs (n=17) 
• Quasi-experimental, pre-post–
intervention studies (n=18) 
• Interrupted time series (n=2) 
• Prospective cohort study (n=1) 
N = 14488 
One study did not 
report sample size 
 
Sample range: 15 – 
4742 
 








• Internet search 
• Compact disc 
• Fax 
• PalmPilot 
• SMS text messaging 
• Efficacy 
• Impact or effectiveness 
• Doctor-patient 
communication 
• ICTs were most commonly used to 
provide information or education, 
serve as decision aids, promote ACP, 
and relieve physical symptom distress. 
Rogante et al. 2016 
33 
(2007-2014) 
To evaluate the 












YES – PRISMA 16 
 
YES - Quality Appraisal: 
AMSTAR (Assessment 
o9f Multiple Systematic  
Reviews) checklist 84 
 
 
Not reported N = 6 reviews 
 
(96 original articles) 
 
• Patients with palliative care 
needs 
Not reported Telemedicine: 
• Telephone advice 
lines 
• Videophones 
• Personal digital 
assistants 
• Pen tablets 
• Computers 
• Clinical health-related 
outcomes 
• QOL 
• Caregiver perceptions of pain 
management 
• Symptom management 
• Patient-physician relationship 
• Pain management 
• Education 
• Advantages/ disadvantages 
• Efficacy of intervention 
• Cost 
• Quality of care 
• Patient acceptance and 
compliance 
• Feasibility 
• All included systematic reviews 
considered telemedicine applications 
as a feasible means to be used in 
palliative care; however, the positive 
findings are counterbalanced by 
several critical issues mainly related to 
the evidence from the primary studies 
included in each single review. 
• Results of this first attempt to appraise 
the evidence in the field of 
telemedicine applications in palliative 
care highlighted that there is still 
limited evidence related to this 
approach. 











YES – PRISMA 16 
 
YES – Quality Appraisal: 
Cochrane 
Collaboration’s tool 81 
Australia, USA, 
Taiwan, Canada 
N = 9 
 
• Pooled analysis of two 
randomised trials (n=1) 
• Randomised non-inferiority trial 
(n=2) 
• Prospective exploratory cohort 
study (n=1) 
• Sequential mixed method two-
phase design (n=1) 
• Two-group non-randomised pre-
test/post-test design (n=1) 
• Mixed-methods analysis of 
multiple data sources (n=1) 
• pilot pre-/post intervention 
N=517 
 
Same range: 8-217 
 










• Caregiver QOL 
• Caregiver mood/anxiety 
• Caregiver burden 
• Family functioning 
• Social support 
• All the studies measuring caregiver 
QOL showed no significant difference 
after telehealth interventions. 
• The caregiver anxiety score decreased 
after the intervention in two studies, 
and one study reported significantly 
reduced caregiver burden.  
• Although feasibility of telehealth or 
caregiver satisfaction with the 
telehealth intervention was not the 
focus of this review, most studies 
reported such findings. 
ACP, advance care planning; AMSTAR, Assessing the Methodological Quality of Systematic Reviews; BP, blood pressure; CASP, Critical Appraisal Skills Programme COPD, chronic obstructive pulmonary disease; EOL, end of life; ESRD, end-stage 
renal disease; GP, general practitioner; HF, heart failure; HIV / AIDS, Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome; HP, health professionals; ICT, information and communication technology N, number; NA, not 
application; NOK, next of kin; QOL, quality of life; PDA, personal digital assistant; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RCT, randomised controlled trial; RPM, remote patient monitoring; SMS, short 
message service; TIDieR, The Template for Intervention Description and Replication 
survey design (n=1) 
• Mixed-method case study (n=1) 
• single-group feasibility study 
(n=1) 
Allsop et al. 2015 29 
(1990 – 2012) 
To review existing 
ICT systems 
intended to support 
management of pain 







YES – PRISMA 16 
 
NO – Quality Appraisal  
USA, Sweden, UK, 
Austria, Germany, 
Japan, Norway 
N = 24 
 






• Randomised experiment (n=4) 
• Non-randomised experiment 
(n=1) 
• Observational (n=1) 
• Survey design (n=2) 
• System description (n=2) 
• Expert opinion (n=1) 
• Non-specified non-experimental 
study design (n=13) 
Not reported 
 




• Management tool 
for remote patient 
identification, 
assessment and 
monitoring of pain 
• Pain assessment • Studies were identified at different 
stages of development with no 
systems having reached 
implementation. 
• Most systems captured pain as part of 
QOL measurement with wide 
variation in approaches to pain 
assessment. 
Table 3. Assessing quality and risk of bias in included reviews using ROBIS phase 2 
domains and phase 3. 


















al. 2020 27 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y  
 
 
2.1 – Y 
2.2 – Y 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – N 
4.6 – Y 
 
 No studies were 
included in the 
synthesis due to 
low quality of 
studies. 
Widberg et 
al. 2020 26 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y  
 
 
2.1 – Y 
2.2 – N 
2.3 – PY 
2.4 – Y 
2.5 – Y 
 
 
3.1 – PY 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – N 
4.6 – N 
? 
 Biases in included 
studies minimally 
addressed in the 
synthesis. 
Portz et al. 
2020 28 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y  
 
 
2.1 – Y 
2.2 – Y 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – N 
3.5 – N 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – N 
4.5 – PN 
4.6 – N 
 
 No critical 
appraisal or risk of 
bias assessed. 
Sutherland 
et al. 2020 
52 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – PY 
2.2 – N 
2.3 – PY 
2.4 – Y 
2.5 – N 
 
? 
3.1 – NI 
3.2 – PN 
3.3 – Y 
3.4 – N 
3.5 – N 
 
? 
4.1 – PY 
4.2 – Y 
4.3 – Y 
4.4 – N 
4.5 – PY 
4.6 – N 
? 




and 1 guideline – 
unusual inclusion. 
Steindal et 
al. 2020 35 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – Y 
2.3 – Y 
2.4 – Y 
2.5 – Y  
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – Y 




al. 2020 48 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – NI 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – Y 
 
  
Jess et al. 
2019 49 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – Y 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 




al. 2019 30 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
2.1 – Y 
2.2 – Y 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – PY 
3.5 – PY 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – Y 
 Although criteria 
used for review of 




    developed by the 
authors and 
assessed by the 
authors, creating 
scope for bias. 
Allsop et al. 
2018 32 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – Y 
2.3 – PY 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – N 
3.5 – N 
 
? 
4.1 – PY 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – N 
? 
? No quality 
assessment was 
used to rate risk of 
bias in included 
studies. 
Lunney et 
al. 2018 31 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – Y 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – N 
3.5 – N 
 
? 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – N 
? 
? No quality 
assessment was 
used to rate risk of 
bias in included 
studies. 
Head et al. 
2017 34 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – N 
2.3 – NI 
2.4 – Y 
2.5 – PY 
 
? 
3.1 – NI 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – NI 
 
? 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – Y 
 
? Very basic search 
terms – no search 
strategy provided. 
Methods section is 
limited. Does not 
explain how the 
quality appraisal 
tool was used and 
how many authors 
performed it. 
Pinto et al. 
2017 53 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – PN 
2.2 – Y 
2.3 – PN 
2.4 – Y 
2.5 – NI 
 
? 
3.1 – PY 
3.2 – Y 
3.3 – Y 
3.4 – N 
3.5 – N 
 
? 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – N 
 
? Surprising that 







appraisal or risk of 
bias assessed. 
Ostherr et 
al. 2016 50 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – N 
2.3 – Y 
2.4 – Y 
2.5 – Y 
 
 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – NI 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 




al. 2016 33 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – N 
2.3 – PY 
2.4 – Y 
2.5 – PY 
 
 
3.1 – PY 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – Y 
 
  
Zheng et al. 
2016 51 
1.1 – Y 
1.2 – Y 
1.3 – Y 
1.4 – Y 
1.5 – Y 
 
 
2.1 – Y 
2.2 – N 
2.3 – PY 
2.4 – Y 
2.5 – NI 
 
? 
3.1 – Y 
3.2 – Y 
3.3 – Y 
3.4 – Y 
3.5 – Y 
 
 
4.1 – Y 
4.2 – Y 
4.3 – Y 
4.4 – Y 
4.5 – PY 
4.6 – Y 
 
 Search terms and 
structure of search 




Allsop et al. 
2015 29 
1.1 – Y 
1.2 – Y 
1.3 – Y 
2.1 – Y 
2.2 – N 
2.3 – Y 
3.1 – Y 
3.2 – Y 
3.3 – Y 
4.1 – Y 
4.2 – Y 
4.3 – Y 
 No critical 
appraisal or risk of 
bias assessed. 
1.4 – Y 
1.5 – Y 
 
 
2.4 – Y 
2.5 – Y 
 
 
3.4 – N 
3.5 – N 
 
? 
4.4 – Y 
4.5 – PN 
4.6 – N 
 
Summary of the ROBIS Assessment. Risk of bias is judged as “low,” “high,” or “unclear.” 
 = low risk;  = high risk; ? = unclear risk 
Table 4. Barriers and facilitators to virtual palliative care strategies 
 Barriers Facilitators 
Systems 
level 
Lack of broadband coverage/ internet access 30, 53 Ease of use / user-friendliness/ simplicity 35, 48, 49 
Lack of adequate resources 49 External support managing coordination of virtual consultations 48, 49 
Quality impacting video and audio resolution 48, 49, 
52 
A need to improve infrastructure to support telehealth/administrative 
support in setting up remote consultations 
30, 52 
Rigid firewalls 48 Better integration between hospital and community services 53 
Security concerns/issues 53 Using a standard operating procedure or clinical protocol stipulating 
when telehealth interventions can/cannot be used 
52 
Slow internet speed 48 
49 
Policies to minimise the risk of reduced equity of access in 
disadvantaged populations 
52 
Lack of leadership and encouragement from management 49   
The system is expensive/ internet access expensive 48   
Lack of funding 30   
Clinician 
level 
Clinician perception that intervention inappropriate for population due to age, 





Positive attitude to video enabled consultations, viewing it as a way to 
enable digital connectedness. Clinicians viewed it as a way to observe 
body language and nonverbal cues. 
35, 48, 
49, 52 
Negative perception of not being able to physically comfort patient or caregiver 48, 52 Clinician training and skill in video consultation technology and how to 
interact and communicate by video. 
49, 52 
Health professional preference for face-to-face 




Lack of consensus among HPs on criteria for appropriate referral of patients for 
virtual/video consultations 




Poor health condition, physical limitations 35 Patient willingness to use telehealth systems 35 
Possible intrusion and reminder of being sick 48 Positive experiences and attitudes to telehealth interventions 52 
Perceived potential for patient difficulty managing the technology 30 Portability of devices 49 
Difficult to discuss sensitive topics 48, 52 Adequate patient/carer training 48, 49, 
52, 53 
Preference for face-to-face 53   
Not comfortable being on video 48   
Unfamiliarity with telehealth equipment / Low literacy or few digital literacy skills 35, 52   
Patients requiring assistance from a third person/family member to use the 
system. 
35   
Challenges with design of equipment e.g. small font size on smartphones, small 
size of videophones, lack of equipment portability 
35   
People with limited control over or access to mobile devices e.g. people speaking 
minority languages, migrant populations in new settings 
52   
Limited access to the required equipment 53   
 
